It is the first test the FDA has cleared for use in symptomatic adults aged 40 and over, according to C2N Diagnostics.

Blood-based test identifies presence of amyloid plaques in symptomatic adults and is intended to be used in conjunction with a clinical assessment ...

Will getting a blood test for amyloid levels eventually form part of routine primary care health checks, or are we putting ...

Acarix AB (publ) today announced the publication of a peer-reviewed study in PLOS Digital Health showing that the seismocardiography (SCG) technology at the heart of its CE-marked, FDA-cleared ...

The Nationals are awaiting test results on Harry Ford after the rookie catcher left Friday’s win over the Angels with hand ...

Aalborg University-led research, published in PLOS Digital Health, found the CADScor System's acoustic sensing platform identified heart failure with diagnostic accuracy comparable to a leading blood ...

Sean Tucker is officially doubtful for the Bucs' opener against the Bengals. Check out Tampa Bay's final Week 1 injury update ...

The US Food and Drug Administration has cleared Roche and partner Eli Lilly’s blood test to help ​identify signs of Alzheimer’s disease in people age ‌55 and older with cognitive decline.

Share on Pinterest Roche and Eli Lilly’s single biomarker Elecsys pTau217 test for Alzheimer’s has received FDA clearance. Maskot/Getty Images On August 24, 2026, the U.S. FDA cleared a new ...

A simple blood draw can now help doctors check for the plaques tied to Alzheimer’s.

At-home DNA tests have revolutionized personal health insights, but understanding their accuracy requires examining the ...